The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Pancreatic Cancer - EP2943192

The patent EP2943192 was granted to Abraxis Bioscience on Sep 29, 2021. The application was originally filed on Jan 10, 2014 under application number EP14737791A. The patent is currently recorded with a legal status of "Revoked".

EP2943192

ABRAXIS BIOSCIENCE
Application Number
EP14737791A
Filing Date
Jan 10, 2014
Status
Revoked
Jun 17, 2022
Publication Date
Sep 29, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ACCORD HEALTHCAREFeb 11, 2022TER MEER STEINMEISTER & PARTNERADMISSIBLE
TEVA PHARMACEUTICALSFeb 10, 2022D YOUNGADMISSIBLE
GENERICS UKJan 17, 2022ELKINGTON AND FIFEADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006263434
DESCRIPTIONUS2007082838
DESCRIPTIONUS2013005678
DESCRIPTIONUS5916596
DESCRIPTIONUS6096331
DESCRIPTIONUS6506405
DESCRIPTIONUS6537579
DESCRIPTIONUS6749868
DESCRIPTIONUS7820788
DESCRIPTIONWO2008137148
DESCRIPTIONWO2011153010
INTERNATIONAL-SEARCH-REPORTWO2011123393
OPPOSITIONUS2006263434
OPPOSITIONWO2011153010
OPPOSITIONWO2014110443
SEARCHWO2011153010

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents